Natalizumab extended interval dosing: What about wearing-off effect?

This study aimed to evaluate the impact of EID in WO in MS patients under natalizumab.

Source: Journal of the Neurological Sciences - February 10, 2024 Category: Neurology Authors: Catarina Bernardes, Catarina Fernandes, Carolina Cunha, Carla Nunes, Carmo Mac ário, Lívia Sousa, Sónia Batista, Inês Correia Source Type: research